Filed: 2/13/2026ACC: 0001213900-26-016236
📋 What this filing means
VIVO CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 47 equity positions with a total reported market value of $1.55B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
47
Positions
$1.55B
Total AUM (reported)
137.95M
Total Shares
Allocation by class
COMMON$1.35B87.1%
SPONSORED ADS$95.64M6.2%
ADR$57.84M3.7%
SHS$38.19M2.5%
ADS$6.72M0.4%
WARRANTS$843.7K0.1%
Portfolio Concentration
Top 3$524.27M33.9%
4–10$404.89M26.2%
11–25$436.31M28.2%
Rest$181.59M11.7%
Top 3 weight
33.9%
Top 10 weight
60.1%
Voting Authority Distribution
Total shares with voting rights: 137.95M
Sole
Full voting authority
137.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole47
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings47
Rows:
Terns Pharmaceuticals Inc
SOLEShares5.35M
TypeSH
Market value$216.02M
13.96%
Sole
5.35M
Shared
0.00
None
0.00
Cidara Therapeutics, Inc.
SOLEShares956.67K
TypeSH
Market value$211.32M
13.66%
Sole
956.67K
Shared
0.00
None
0.00
Praxis Precision Medicines
SOLEShares328.89K
TypeSH
Market value$96.94M
6.27%
Sole
328.89K
Shared
0.00
None
0.00
Cogent Biosciences Inc
SOLEShares2.40M
TypeSH
Market value$85.21M
5.51%
Sole
2.40M
Shared
0.00
None
0.00
Trevi Therapeutics Inc
SOLEShares5.09M
TypeSH
Market value$63.79M
4.12%
Sole
5.09M
Shared
0.00
None
0.00
Avadel Pharmaceuticals PLC
SOLEShares2.68M
TypeSH
Market value$57.84M
3.74%
Sole
2.68M
Shared
0.00
None
0.00
Compass Therapeutics Inc
SOLEShares9.55M
TypeSH
Market value$51.26M
3.31%
Sole
9.55M
Shared
0.00
None
0.00
Dyne Therapeutics Inc
SOLEShares2.61M
TypeSH
Market value$51.15M
3.31%
Sole
2.61M
Shared
0.00
None
0.00
Abivax SA - ADR
SOLEShares359.31K
TypeSH
Market value$48.45M
3.13%
Sole
359.31K
Shared
0.00
None
0.00
DBV Technologies SA
SOLEShares2.46M
TypeSH
Market value$47.19M
3.05%
Sole
2.46M
Shared
0.00
None
0.00
SAB Biotherapeutics Inc
SOLEShares11.42M
TypeSH
Market value$42.71M
2.76%
Sole
11.42M
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares894.91K
TypeSH
Market value$41.43M
2.68%
Sole
894.91K
Shared
0.00
None
0.00
Bright Minds Biosciences Inc
SOLEShares501.62K
TypeSH
Market value$39.15M
2.53%
Sole
501.62K
Shared
0.00
None
0.00
Sinovac Biotech Ltd.
SOLEShares5.90M
TypeSH
Market value$38.19M
2.47%
Sole
5.90M
Shared
0.00
None
0.00
Geron Corp
SOLEShares27.23M
TypeSH
Market value$35.94M
2.32%
Sole
27.23M
Shared
0.00
None
0.00
Erasca Inc
SOLEShares9.27M
TypeSH
Market value$34.50M
2.23%
Sole
9.27M
Shared
0.00
None
0.00
Zenas Biopharma Inc
SOLEShares853.50K
TypeSH
Market value$30.99M
2.00%
Sole
853.50K
Shared
0.00
None
0.00
Viridian Therapeutics Inc
SOLEShares982.58K
TypeSH
Market value$30.58M
1.98%
Sole
982.58K
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc.
SOLEShares8.89M
TypeSH
Market value$26.76M
1.73%
Sole
8.89M
Shared
0.00
None
0.00
CAMP4 Therapeutics Inc
SOLEShares4.25M
TypeSH
Market value$26.03M
1.68%
Sole
4.25M
Shared
0.00
None
0.00
Tango Therapeutics Inc
SOLEShares2.15M
TypeSH
Market value$19.09M
1.23%
Sole
2.15M
Shared
0.00
None
0.00
Alto Neuroscience Inc
SOLEShares1.04M
TypeSH
Market value$18.43M
1.19%
Sole
1.04M
Shared
0.00
None
0.00
LB Pharmaceuticals Inc
SOLEShares800K
TypeSH
Market value$17.81M
1.15%
Sole
800K
Shared
0.00
None
0.00
Minerva Neurosciences Inc
SOLEShares4.32M
TypeSH
Market value$17.38M
1.12%
Sole
4.32M
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares2.12M
TypeSH
Market value$17.33M
1.12%
Sole
2.12M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Terns Pharmaceuticals IncSOLE | Common | 5.35M | SH | $216.02M 13.96% | 5.35M | 0.00 | 0.00 |
Cidara Therapeutics, Inc.SOLE | Common | 956.67K | SH | $211.32M 13.66% | 956.67K | 0.00 | 0.00 |
Praxis Precision MedicinesSOLE | Common | 328.89K | SH | $96.94M 6.27% | 328.89K | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | Common | 2.40M | SH | $85.21M 5.51% | 2.40M | 0.00 | 0.00 |
Trevi Therapeutics IncSOLE | Common | 5.09M | SH | $63.79M 4.12% | 5.09M | 0.00 | 0.00 |
Avadel Pharmaceuticals PLCSOLE | ADR | 2.68M | SH | $57.84M 3.74% | 2.68M | 0.00 | 0.00 |
Compass Therapeutics IncSOLE | Common | 9.55M | SH | $51.26M 3.31% | 9.55M | 0.00 | 0.00 |
Dyne Therapeutics IncSOLE | Common | 2.61M | SH | $51.15M 3.31% | 2.61M | 0.00 | 0.00 |
Abivax SA - ADRSOLE | SPONSORED ADS | 359.31K | SH | $48.45M 3.13% | 359.31K | 0.00 | 0.00 |
DBV Technologies SASOLE | SPONSORED ADS | 2.46M | SH | $47.19M 3.05% | 2.46M | 0.00 | 0.00 |
SAB Biotherapeutics IncSOLE | Common | 11.42M | SH | $42.71M 2.76% | 11.42M | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | Common | 894.91K | SH | $41.43M 2.68% | 894.91K | 0.00 | 0.00 |
Bright Minds Biosciences IncSOLE | Common | 501.62K | SH | $39.15M 2.53% | 501.62K | 0.00 | 0.00 |
Sinovac Biotech Ltd.SOLE | SHS | 5.90M | SH | $38.19M 2.47% | 5.90M | 0.00 | 0.00 |
Geron CorpSOLE | Common | 27.23M | SH | $35.94M 2.32% | 27.23M | 0.00 | 0.00 |
Erasca IncSOLE | Common | 9.27M | SH | $34.50M 2.23% | 9.27M | 0.00 | 0.00 |
Zenas Biopharma IncSOLE | Common | 853.50K | SH | $30.99M 2.00% | 853.50K | 0.00 | 0.00 |
Viridian Therapeutics IncSOLE | Common | 982.58K | SH | $30.58M 1.98% | 982.58K | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | Common | 8.89M | SH | $26.76M 1.73% | 8.89M | 0.00 | 0.00 |
CAMP4 Therapeutics IncSOLE | Common | 4.25M | SH | $26.03M 1.68% | 4.25M | 0.00 | 0.00 |
Tango Therapeutics IncSOLE | Common | 2.15M | SH | $19.09M 1.23% | 2.15M | 0.00 | 0.00 |
Alto Neuroscience IncSOLE | Common | 1.04M | SH | $18.43M 1.19% | 1.04M | 0.00 | 0.00 |
LB Pharmaceuticals IncSOLE | Common | 800K | SH | $17.81M 1.15% | 800K | 0.00 | 0.00 |
Minerva Neurosciences IncSOLE | Common | 4.32M | SH | $17.38M 1.12% | 4.32M | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | Common | 2.12M | SH | $17.33M 1.12% | 2.12M | 0.00 | 0.00 |
Page 1 of 2